3-aminobenzamide has been researched along with Basedow Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiromatsu, Y | 1 |
| Sato, M | 1 |
| Yamada, K | 1 |
| Nonaka, K | 1 |
1 other study available for 3-aminobenzamide and Basedow Disease
| Article | Year |
|---|---|
Nicotinamide and 3-aminobenzamide inhibit recombinant human interferon-gamma-induced HLA-DR antigen expression, but not HLA-A, B, C antigen expression, on cultured human thyroid cells.
Topics: Benzamides; Cells, Cultured; Flow Cytometry; Graves Disease; HLA-A Antigens; HLA-B Antigens; HLA-C A | 1992 |